This plain language summary from Future Cardiology describes the results of a study looking at the effects of a medicine called ARRY-371797 (also known as PF-07265803) in people with dilated cardiomyopathy caused by a faulty LMNA gene.

Read the full article here.

The original article on which this plain language summary is based is titled ‘Efficacy and Safety of ARRY-371797 in LMNA-Related Dilated Cardiomyopathy: A Phase 2 Study’ and was published in Circulation: Genomic and Precision Medicine. Read the original article here.